As of close of business last night, Gossamer Bio Inc’s stock clocked out at $1.03, down -3.74% from its previous closing price of $1.07. On the day, 1658187 shares were traded.
Ratios:
To gain a deeper understanding of GOSS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.94 and its Current Ratio is at 5.94. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.15.
On July 27, 2023, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $8 to $1.25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Hasnain Faheem sold 23,172 shares for $1.16 per share. The transaction valued at 26,773 led to the insider holds 120,293 shares of the business.
Giraudo Bryan sold 6,430 shares of GOSS for $7,431 on Mar 27 ’24. The COO/CFO now owns 92,737 shares after completing the transaction at $1.16 per share. On Mar 27 ’24, another insider, Christian Waage, who serves as the EVP, Tech Ops and Admin of the company, sold 6,430 shares for $1.16 each. As a result, the insider received 7,430 and left with 585,934 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 232.35M and an Enterprise Value of 148.39M.
Stock Price History:
Over the past 52 weeks, GOSS has reached a high of $1.88, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 1.1629, while the 200-Day Moving Average is calculated to be 1.0117.
Shares Statistics:
It appears that GOSS traded 1.21M shares on average per day over the past three months and 1.77M shares per day over the past ten days. A total of 225.41M shares are outstanding, with a floating share count of 188.84M. Insiders hold about 16.29% of the company’s shares, while institutions hold 79.45% stake in the company. Shares short for GOSS as of Mar 15, 2024 were 11.09M with a Short Ratio of 9.19, compared to 15.3M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.91% and a Short% of Float of 5.77%.
Earnings Estimates
As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.19 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.23, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.59 and -$0.94 for the fiscal current year, implying an average EPS of -$0.76. EPS for the following year is -$0.69, with 10 analysts recommending between -$0.46 and -$1.
